Home Infusion Therapy Market Analysis By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-Infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals) And Segment Forecasts To 2022

$4,700

Global home infusion therapy market is expected to reach USD 31.9 billion by 2022. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients…………..

Total Pages: 81 

global-home-infusion-therapy-market-expected-reach-usd-31-9-billion-2022-rising-incidence-chronic-disorders-led-augmentation-demand-infusion-therapy-outpatient-set
600
#962f22

Global home infusion therapy market is expected to reach USD 31.9 billion by 2022. Rising incidence of chronic disorders has led to an augmentation in the demand for infusion therapy in outpatient settings, thereby boosting the home infusion therapy market. Rapidly growing geriatric population base globally, is also likely to serve this market as a high impact rendering driver. The home infusion therapy is considered beneficial for patients as they get the entire treatment at the comfort of their home. Furthermore, home infusion therapy is a cost effective alternative to placement in hospital, and allows patients to adhere to their normal lifestyle while receiving treatment. Rising incidences of hospital acquired infections is a high impact rendering driver of this market. Additional healthcare spending associated with these infections are expected to encourage patients to prefer home care over the conventional settings.

Further key findings from the study suggest:

Needleless connectors are expected to witness lucrative growth over the forecast period. Growing demand for enhanced healthcare service provider safety has led to the rise in demand for needleless connectors.
Anti-Infective dominated the market with a revenue share of over 25.0% in 2014. Home administration of anti-infective therapy is preferred by patients who have chronic infections that cannot be treated through oral agents. It is considered as the most user friendly home infusion therapy.

North America accounted for more than 40% of the home infusion therapy market in 2014 on account of the presence of large geriatric population base. Presence of sophisticated healthcare infrastructure and favorable reimbursement plans laid out by regulatory bodies are also expected to make significant contributions towards market growth.

Asia Pacific is expected to emerge as a high growth market over the forecast period. Presence of large unmet needs in the emerging economies such as China and India. Rising patient awareness levels regarding the benefits of home infusion therapies over the in-hospital infusion therapies is expected to further boost the growth of this region.

Key players of home infusion therapy market include B. Braun Melsungen AG, Fresenius Kabi AG, Baxter, CareFusion Corporation and Hospira Inc. Mergers and acquisitions and entering into strategic collaborations with healthcare providers are two key sustainability strategies adopted by these market participants.

For the purpose of this study, Grand View Research has segmented the global home infusion therapy market on the basis of products, application, and region:

Global Home Infusion Therapy Product Outlook (Revenue, USD Million, 2012 – 2022)

Infusion pumps
Intravenous Sets
IV Cannulas
Needleless Connectors

Global Home Infusion Therapy Application Outlook (Revenue, USD Million, 2012 – 2022)

Anti-Infective
Hydration Therapy
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceutical
Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2012 – 2022)

North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA)
South Africa

Table of Contents

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumption
1.3. List of Data Sources

Chapter 2. Executive Summary
2.1. Home Infusion Therapy - Industry Summary and Key Buying Criteria, 2012 - 2022

Chapter 3. Home Infusion Therapy Industry Outlook
3.1. Home infusion therapy market segmentation

3.2. Home infusion therapy market size and growth prospects

3.3. Home infusion therapy market dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis

3.4. Key opportunities prioritized

3.5. Industry analysis - Porter's

3.6. Home infusion therapy market PESTEL analysis, 2014

3.7. Home infusion therapy - Unmet need analysis

Chapter 4. Home Infusion Therapy Product Outlook
4.1. Home infusion therapy market share by product, 2014 & 2022

4.2. Infusion pumps
4.2.1. Infusion pumps market estimates and forecasts, 2012 – 2022 (USD Million)

4.3. Intravenous sets
4.3.1. Intravenous sets market estimates and forecasts, 2012 – 2022 (USD Million)

4.4. Needleless connectors
4.4.1. Needleless connectors market estimates and forecasts, 2012 – 2022 (USD Million)

Chapter 5. Home Infusion Therapy Application Outlook
5.1. Home infusion therapy market share by application, 2014 & 2022

5.2. Anti-infective
5.2.1. Anti-infective market estimates and forecasts, 2012 – 2022 (USD Million)

5.3. Hydration therapy
5.3.1. Hydration therapy market estimates and forecasts, 2012 – 2022 (USD Million)

5.4. Chemotherapy
5.4.1. Chemotherapy market estimates and forecasts, 2012 – 2022 (USD Million)

5.5. Enteral Nutrition
5.5.1. Enteral nutrition market estimates and forecasts, 2012 – 2022 (USD Million)

5.6. Parenteral nutrition
5.6.1. Parenteral nutrition market estimates and forecasts, 2012 – 2022 (USD Million)

5.7. Specialty pharmaceuticals
5.7.1. Specialty pharmaceuticals market estimates and forecasts, 2012 – 2022 (USD Million)

5.8. Others
5.8.1. Others market estimates and forecasts, 2012 – 2022 (USD Million)

Chapter 6. Home infusion therapy Regional Outlook
6.1. Home infusion therapy market share by region, 2014 & 2022

6.2. North America
6.2.1. North America home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.2.1.1. U.S. market estimates and forecasts
6.2.1.2. Canada market estimates and forecasts
6.2.2. North America home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.2.2.1. U.S. market estimates and forecasts
6.2.2.2. Canada market estimates and forecasts

6.3. Europe
6.3.1. Europe home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.3.1.1. Germany market estimates and forecasts
6.3.1.2. UK market estimates and forecasts
6.3.2. Europe home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.3.2.1. Germany market estimates and forecasts
6.3.2.2. UK market estimates and forecasts

6.4. Asia Pacific
6.4.1. Asia Pacific home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.4.1.1. China market estimates and forecasts
6.4.1.2. Japan market estimates and forecasts
6.4.2. Asia Pacific home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)
6.4.2.1. China market estimates and forecasts
6.4.2.2. Japan market estimates and forecasts

6.5. Latin America
6.5.1. Latin America home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.5.2. Latin America home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)

6.6. MEA
6.6.1. MEA home infusion therapy market estimates and forecasts, by product, 2012 – 2022 (USD Million)
6.6.2. MEA home infusion therapy market estimates and forecasts, by application, 2012 – 2022 (USD Million)

Chapter 7. Competitive Landscape
7.1. Terumo Corporation
7.1.1. Company Overview
7.1.2. Financial Performance
7.1.3. Product Benchmarking
7.1.4. Strategic Initiatives

7.2. B. Braun Melsungen
7.2.1. Company Overview
7.2.2. Financial Performance
7.2.3. Product Benchmarking
7.2.4. Strategic Initiatives

7.3. Caesarea Medical Electronics
7.3.1. Company Overview
7.3.2. Financial Performance
7.3.3. Product Benchmarking
7.3.4. Strategic Initiatives

7.4. Smiths Medical
7.4.1. Company Overview
7.4.2. Financial Performance
7.4.3. Product Benchmarking
7.4.4. Strategic Initiatives

7.5. CareFusion Corporation
7.5.1. Company Overview
7.5.2. Financial Performance
7.5.3. Product Benchmarking
7.5.4. Strategic Initiatives

7.6. ICU Medical Inc.
7.6.1. Company Overview
7.6.2. Financial Performance
7.6.3. Product Benchmarking
7.6.4. Strategic Initiatives

7.7. JMS Co. Ltd.
7.7.1. Company Overview
7.7.2. Financial Performance
7.7.3. Product Benchmarking
7.7.4. Strategic Initiatives

7.8. Baxter Inc.
7.8.1. Company Overview
7.8.2. Financial Performance
7.8.3. Product Benchmarking
7.8.4. Strategic Initiatives

7.9. Fresenius Kabi
7.9.1. Company Overview
7.9.2. Financial Performance
7.9.3. Product Benchmarking
7.9.4. Strategic Initiatives
List of Tables
1. Home Infusion Therapy– Industry Summary and Key Buying Criteria
2. Home Infusion Therapy Market by Product, (USD million), 2012 – 2022
3. Home Infusion Therapy Market by Application, (USD million), 2012 – 2022
4. Home Infusion Therapy Market by Region, (USD million), 2012 – 2022
5. Home Infusion Therapy Market – Key market drivers analysis
6. Home Infusion Therapy Market – Key market restraints analysis
7. Infusion Pumps Market, 2012 to 2022 (USD million)
8. Intravenous Sets Market, 2012 to 2022 (USD million)
9. IV Cannulas Market, 2012 to 2022 (USD million)
10. Needle Less Connectors Market, 2012 to 2022 (USD million)
11. Anti-Infective Market, 2012 to 2022 (USD million)
12. Hydration Therapy Market, 2012 to 2022 (USD million)
13. Chemotherapy Market, 2012 to 2022 (USD million)
14. Enteral Nutrition Market, 2012 to 2022 (USD million)
15. Parenteral Nutrition Market, 2012 to 2022 (USD million)
16. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
17. Others Market, 2012 to 2022 (USD million)
18. Global Home Infusion Therapy Market, By Region, 2012 to 2022 (USD million)
19. North America Home Infusion Therapy Demand, By Product, (USD million), 2012 – 2022
20. North America Home Infusion Therapy Demand, By Application, (USD million), 2012 – 2022
21. Europe Home Infusion Therapy Demand, By Products, (USD million), 2012 – 2022
22. Europe Home Infusion Therapy Demand, By Applications, (USD million), 2012 – 2022
23. Asia Pacific Home Infusion Therapy Demand, By Products, (USD million), 2012 – 2022
24. Asia Pacific Home Infusion Therapy Demand, By Applications, (USD million), 2012 – 2022
25. Latin America Home Infusion Therapy Demand, By Products, (USD million), 2012 – 2022
26. Latin America Home Infusion Therapy Demand, By Application, (USD million), 2012 – 2022
27. MEA Home Infusion Therapy Demand, By Products, (USD million), 2012 – 2022
28. MEA Home Infusion Therapy Demand, By Application, (USD million), 2012 – 2022
List of Figures
1. Home Infusion Therapy Market Segmentation
2. Global Home Infusion Therapy Market Revenue, 2012 - 2022
3. Home Infusion Therapy Market Dynamics
4. Key Opportunities Prioritized
5. Industry Analysis - Porter's
6. Home Infusion Therapy PESTEL Analysis, 2012
7. Global Home Infusion Therapy Market , By Product, (USD million), 2012 – 2022
8. Infusion Pumps Market, 2012 to 2022 (USD million)
9. Intravenous Sets Market, 2012 to 2022 (USD million)
10. IV Cannulas Market, 2012 to 2022 (USD million)
11. Needleless Connectors Market, 2012 to 2022 (USD million)
12. Global Home Infusion Therapy Market , By Application, (USD million), 2012 – 2022
13. Anti-Infective Market, 2012 to 2022 (USD million)
14. Hydration Therapy Market, 2012 to 2022 (USD million)
15. Chemotherapy Market, 2012 to 2022 (USD million)
16. Enteral Nutrition Market, 2012 to 2022 (USD million)
17. Parenteral Nutrition Market, 2012 to 2022 (USD million)
18. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
19. Others Market, 2012 to 2022 (USD million)
20. Global Home Infusion Therapy Market, By Region 2012 to 2022 (USD million)
21. Infusion Pumps Market, 2012 to 2022 (USD million)
22. Intravenous Sets Market, 2012 to 2022 (USD million)
23. IV Cannulas Market, 2012 to 2022 (USD million)
24. Needleless Connectors Market, 2012 to 2022 (USD million)
25. Anti-Infective Market, 2012 to 2022 (USD million)
26. Hydration Therapy Market, 2012 to 2022 (USD million)
27. Chemotherapy Market, 2012 to 2022 (USD million)
28. Enteral Nutrition Market, 2012 to 2022 (USD million)
29. Parenteral Nutrition Market, 2012 to 2022 (USD million)
30. Specialty Pharmaceuticals Market, 2012 to 2022 (USD million)
31. Others Market, 2012 to 2022 (USD million)
32. Home Infusion Therapy market - Company market share analysis, 2014 (%)


LICENSE TYPE